Gear up for AACR24!
See Biotech companies with cancer assets 👇
⇨ held by 5 biopharma-focused hedge funds! 🔥
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx(ACLX.US$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics(ADAP.US$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics(BCYC.US$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals(CNTA.US$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals(DAWN.US$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics(FATE.US$ : FT576 (Ph 1)
$Fusion Pharmaceuticals(FUSN.US$ : FPI-2265 (Ph 2)
$GRCL: GC012F (Ph 1/2)
$Inhibrx(INBX.US$ : INBRX-109 (Ph 2)
$RAPT Therapeutics(RAPT.US$ : Tivumecirnon (Ph 2)
$Arcus Biosciences(RCUS.US$ : Domvanalimab (Ph 2/3)
$Relay Therapeutics(RLAY.US$ : RLY-4008 (Lirafugratinib) (Ph 1/2)
$Sutro Biopharma(STRO.US$ : Luveltamab Tazevibulin (Ph 2/3)
$SpringWorks Therapeutics(SWTX.US$ : Nirogacestat (Ph 2)
$Zymeworks(ZYME.US$ : Zanidatamab (BLA)
$Adaptimmune Therapeutics(ADAP.US$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics(BCYC.US$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals(CNTA.US$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals(DAWN.US$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics(FATE.US$ : FT576 (Ph 1)
$Fusion Pharmaceuticals(FUSN.US$ : FPI-2265 (Ph 2)
$GRCL: GC012F (Ph 1/2)
$Inhibrx(INBX.US$ : INBRX-109 (Ph 2)
$RAPT Therapeutics(RAPT.US$ : Tivumecirnon (Ph 2)
$Arcus Biosciences(RCUS.US$ : Domvanalimab (Ph 2/3)
$Relay Therapeutics(RLAY.US$ : RLY-4008 (Lirafugratinib) (Ph 1/2)
$Sutro Biopharma(STRO.US$ : Luveltamab Tazevibulin (Ph 2/3)
$SpringWorks Therapeutics(SWTX.US$ : Nirogacestat (Ph 2)
$Zymeworks(ZYME.US$ : Zanidatamab (BLA)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment